Viral Shedding with Asymptomatic HSV-2 Infection

Richard T. Ellison III, MD


Journal Watch 

In This Article


These data indicate that the risk for transmission from asymptomatic HSV-2 disease is not insignificant and that continued efforts to protect against HSV-2 (e.g., through vaccines, barrier precautions, and yet-to-be-developed topical antiviral compounds) are worthwhile.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.